Michael J. Jung

3.3k total citations · 3 hit papers
43 papers, 2.7k citations indexed

About

Michael J. Jung is a scholar working on Accounting, Finance and Molecular Biology. According to data from OpenAlex, Michael J. Jung has authored 43 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Accounting, 19 papers in Finance and 15 papers in Molecular Biology. Recurrent topics in Michael J. Jung's work include Corporate Finance and Governance (20 papers), Financial Markets and Investment Strategies (19 papers) and Auditing, Earnings Management, Governance (19 papers). Michael J. Jung is often cited by papers focused on Corporate Finance and Governance (20 papers), Financial Markets and Investment Strategies (19 papers) and Auditing, Earnings Management, Governance (19 papers). Michael J. Jung collaborates with scholars based in United States, France and Canada. Michael J. Jung's co-authors include Brian W. Metcalf, Charles Danzin, Philippe Bey, Patrick Casara, Jean‐Paul Vevert, Bruce Lippert, Peter Böhlen, Paul J. Schechter, Gregory S. Miller and Brian J. Bushee and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Michael J. Jung

40 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs

1978 880 citations Brian W. Metcalf, Philippe Bey et al. profile →
γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE¹

1977 417 citations Michael J. Jung, Bruce Lippert et al. Journal of Neurochemistry profile →
Do Firms Strategically Disseminate? Evidence from Corporate Use of Social Media

2017 246 citations Michael J. Jung et al. The Accounting Review profile →

Peers

Countries citing papers authored by Michael J. Jung

Since Specialization

Citations

This map shows the geographic impact of Michael J. Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Jung more than expected).

Fields of papers citing papers by Michael J. Jung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Jung. The network helps show where Michael J. Jung may publish in the future.

Co-authorship network of co-authors of Michael J. Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Jung. A scholar is included among the top collaborators of Michael J. Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Jung. Michael J. Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Does high-frequency trading cause stock prices to deviate from fundamental values? 2023 ·Accounting and Business Research ·Michael J. Jung, (unknown), (unknown)	1
2	Does lowball guidance work? An analysis of firms that consistently beat their guidance by large margins 2023 ·The British Accounting Review ·Jing Chen, Michael J. Jung, (unknown)	0
3	Analyst Contrarianism 2019 ·Zahn Bozanic, Jing Chen, Michael J. Jung	5
4	Do Investors Benefit from Selective Access to Management? 2017 ·Brian J. Bushee, Michael J. Jung, Gregory S. Miller	106
5	Buy-Side Analysts and Earnings Conference Calls 2016 ·SSRN Electronic Journal ·Michael J. Jung, M.H. Franco Wong, Frank Zhang	2
6	The Confirmation Effect of Analyst Recommendation Reiterations 2016 ·Journal of Accounting Auditing & Finance ·Jing Chen, Michael J. Jung, Joshua Ronen	2
7	Readability evaluation of Internet-based patient education materials related to the anesthesiology field 2015 ·Journal of Clinical Anesthesia ·Gildàsio S. De Oliveira, Michael J. Jung, Kirsten McCaffery, Robert J. McCarthy, Michael S. Wolf	29
8	Analyst Interest as an Early Indicator of Firm Fundamental Changes and Stock Returns 2014 ·The Accounting Review ·Michael J. Jung, M.H. Franco Wong, Frank Zhang	30
9	Conference Presentations and the Disclosure Milieu 2011 ·Journal of Accounting Research ·Brian J. Bushee, Michael J. Jung, Gregory S. Miller	64
10	Synthesis and inhibitory properties of α(chlorofluoromethyl)-α-amino acids, a novel class of irreversible inactivators of decarboxylases 1992 ·Journal of the Chemical Society Perkin Transactions 1 ·Daniel Schirlin, Jean‐Bernard Ducep, (unknown), Philippe Bey, François Piriou, Joseph E. Wagner, Jean‐Marie Hornsperger, (unknown), Michael J. Jung, Charles Danzin, R. Weiss, J. FISCHER, A. Mitschler, A. De Cian	11
11	Synthesis and biological properties of .alpha.-mono and .alpha.-difluoromethyl derivatives of tryptophan and 5-hydroxytryptophan 1988 ·Journal of Medicinal Chemistry ·Daniel Schirlin, F. Gerhart, Jean‐Marie Hornsperger, M. Hamon, Joseph E. Wagner, Michael J. Jung	70
12	Preliminary communications 1984 ·Biochemical Pharmacology ·Michael J. Jung, (unknown), Patrick Casara	11
13	Lack of stringent stereospecificity in the inactivation of pyridoxal phosphate-dependent enzymes by suicide-substrates. 1984 ·PubMed ·Charles Danzin, Michael J. Jung	2
14	(2R,5R)-6-heptyne-2,5-diamine, an extremely potent inhibitor of mammalian ornithine decarboxylase 1983 ·Biochemical and Biophysical Research Communications ·Charles Danzin, Patrick Casara, Nicole Claverie, Brian W. Metcalf, Michael J. Jung	37
15	Selective irreversible inhibition of mammalian histidine decarboxylase by α-chloromethyl histidine 1979 ·Inflammation Research ·Bruce Lippert, Philippe Bey, (unknown), Jean Paul Vevert, Charles Danzin, G. Ribéreau-Gayon, Michael J. Jung	6
16	Inhibition of monoamine synthesis by irreversible blockade of aromatic aminoacid decarboxylase with α-monofluoromethyldopa 1979 ·Life Sciences ·Michael J. Jung, Michael G. Palfreyman, Joseph E. Wagner, Philippe Bey, G. Ribéreau-Gayon, M. Zraïka, Jan Koch‐Weser	47
17	Analogs of ornithine as inhibitors of ornithine decarboxylase. New deductions concerning the topography of the enzyme's active site 1978 ·Journal of Medicinal Chemistry ·Philippe Bey, Charles Danzin, V. Van Dorsselaer, Pierre S. Mamont, Michael J. Jung, Chantal Tardif	75
18	Enzyme-activated irreversible inhibitors of L-ornithine:2-oxoacid aminotransferase. Demonstration of mechanistic features of the inhibition of ornithine aminotransferase by 4-aminohex-5-ynoic acid and gabaculine and correlation with in vivo activity. 1978 ·Journal of Biological Chemistry ·Michael J. Jung, Nikolaus Seiler	91
19	γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE¹ breakdown → 1977 ·Journal of Neurochemistry ·Michael J. Jung, Bruce Lippert, Brian W. Metcalf, Peter Böhlen, Paul J. Schechter	417
20	Preparation and properties of 3‐cyano pyridine ad⁺, a new analogue of nad⁺ 1970 ·FEBS Letters ·J.F. Biellmann, Michael J. Jung	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact